Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Bridgebio Oncology Therapeutics Inc. > Profile

Bridgebio Oncology Therapeutics Inc. (BBOT)

Market is closed
Sector: Healthcare

Insider Roster

Show All Insiders (22)
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
Chen
 $10.00 903,600 $9,036,000.00 903,600 2024-02-13 Filing
Chen
 $10.00 1,427,040 $14,270,400.00 1,427,040 2024-02-13 Filing
Chen
 $10.00 69,360 $693,600.00 69,360 2024-02-13 Filing
News See All
Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?

Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts.  BridgeBio Oncology Therapeutics, Inc.

Keep Reading →

June 30th, 2026 - News

10 Most Promising Cancer Stocks According to Wall Street Analysts

10 Most Promising Cancer Stocks According to Wall Street Analysts

Regardless of the state of the economy, the pharmaceutical business has continued to be one of the healthcare market's most robust sectors thanks to the consistent need for medications, vaccinations, ...

Keep Reading →

June 28th, 2026 - Hedge Funds News

Click here to See All News
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.